Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Tata India Pharma & Healthcare Fund | Edelweiss Recently Listed IPO Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Regular | Regular |
| Fund house | Tata | Edelweiss |
| NAV | ₹33.9323 | ₹33.4822 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 10.9 years | 8.7 years |
| Expense ratio | 2.4% | 2.7% |
| Stars | ★★★★★ | ★★★★★ |
| Growth Score | 65.70 | 44.70 |
Returns
| Tata India Pharma & Healthcare Fund | Edelweiss Recently Listed IPO Fund | |
|---|---|---|
| 1 month | +9.73% | +5.80% |
| 3 months | +0.76% | +2.08% |
| 6 months | +6.88% | +19.60% |
| YTD | +12.33% | +23.82% |
| 1 year | +10.25% | +22.21% |
| 3 years (CAGR) | +17.02% | +15.66% |
| 5 years (CAGR) | +14.30% | +9.59% |
| 10 years (CAGR) | +14.17% | — |
| Since launch | +11.82% | +14.82% |
Risk
| Tata India Pharma & Healthcare Fund | Edelweiss Recently Listed IPO Fund | |
|---|---|---|
| Volatility | 15.7% | 20.9% |
| Downside volatility | 10.1% | 13.1% |
| Sharpe | 0.67 | 0.44 |
| Sortino | 1.04 | 0.70 |
| Calmar | 1.00 | 0.63 |
| Return / risk | 1.09 | 0.75 |
| Deepest fall | −21.94% | −32.34% |
| Days to recover | 624 | 155 |
| Below its high | −0.20% | −1.65% |
Against benchmark
| Tata India Pharma & Healthcare Fund | Edelweiss Recently Listed IPO Fund | |
|---|---|---|
| Alpha | −4.21% | +4.43% |
| Beta | 1.00 | 0.97 |
| R² | 90.2% | 56.3% |
| Up capture | 88.9% | 111.0% |
| Down capture | 105.4% | 96.2% |
| Tracking error | 4.9% | 13.8% |
| Information ratio | −0.87 | 0.31 |
| Treynor | 0.09 | 0.09 |
Consistency
| Tata India Pharma & Healthcare Fund | Edelweiss Recently Listed IPO Fund | |
|---|---|---|
| Best 1-year | +73.72% | +97.69% |
| Middle 1-year | +7.27% | +16.18% |
| Worst 1-year | −18.70% | −24.34% |
| 1-year periods with a loss | 33.4% | 26.2% |
| Middle 3-year | +19.29% | +17.58% |
| Positive months | 61.1% | 66.7% |
| Best day | +3.33% | +3.68% |
| Worst day | −3.10% | −5.79% |
| Worst 5% day | −1.35% | −1.94% |
| Positive days | 54.9% | 57.4% |
| NAVs a year | 247 | 247 |
SIP of ₹10,000 a month
| Tata India Pharma & Healthcare Fund | Edelweiss Recently Listed IPO Fund | |
|---|---|---|
| 5-year XIRR | +16.33% | +16.40% |
| 5-year value | ₹9,09,680 | ₹9,11,471 |
| 3-year XIRR | +11.67% | +16.90% |
| 1-year XIRR | +16.78% | +33.64% |
Holdings overlap i
Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.